FedEx Express has launched the FedEx Life Science Center (LSC) in Mumbai, India, that will meet and support the clinical trial storage and logistics requirements of healthcare customers, both within the India market and those shipping to India from around the world.
The facility is compliant with quality and regulatory requirements of the healthcare industry and includes three temperature-controlled zones.
Nitin Navneet Tatiwala, vice president of FedEx Express, Marketing, Middle East, India Sub-continent & Africa (MEISA), said, “With FedEx having deep expertise in handling critical clinical trial shipments, the launch of FedEx Life Science Center will act as a one-stop shop for all clinical trial storage and distribution requirements of healthcare customers in India.
“The new center is in addition to FedEx’s current LSCs in Japan, South Korea, Singapore, the USA and the Netherlands – making it a global network of storage and distribution depots to support our healthcare and pharmaceutical customers.”
FedEx offers door-to-door delivery across more than 6,000 postal codes within India for time-critical and temperature-controlled healthcare shipments. This service ensures express delivery within 24-48 hours in major metropolitan areas such as Mumbai, Bengaluru, Hyderabad, Pune, Chennai, Delhi, Kolkata and Ahmedabad.
FedEx has over 90 cold-storage facilities worldwide and offers FedEx Customized Freight (FCF) for the transportation of critical pharmaceutical freight shipments.